Preferential expression of 5-HT(1D) over 5-HT(1B) receptors during early embryogenesis

NeuroReport

Volumn 8, Issue 17, 1997, Pages 3655-3660

  Bolaños Jiménez, Francisco ^a   Choi, Doo Sup ^a   Maroteaux, Luc ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

5 HT(1B) receptors; 5 HT(1D) receptors; CNS; Development; Embryogenesis; Mouse; Serotonin

Indexed keywords

RECEPTOR SUBTYPE; SEROTONIN 1D RECEPTOR;

ARTICLE; CELL PROLIFERATION; EMBRYO; EMBRYO DEVELOPMENT; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY;

EID: 0031469002     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199712010-00001     Document Type: Article

References (26)

1. Boess FG and Martin IL. Neuropharmacology 33, 275-317 (1994).
2. Hoyer D, Clarcke DE, Fozard JF et al. Pharmacol Rev 46, 157-203 (1994).
3. Maroteaux L, Saudou F, Amlaiky N et al. Proc Natl Acad Sci USA 89, 3020-3024 (1992).
4. Bruinvels AT, Palacios JM and Hoyer D. Naunyn Schmiedeberg's Arch Pharmacol 347, 569-582 (1993).
5. Bruinvels AT, Palacios JM, Hoyer D et al. Neuropharmacology 33, 367-386 (1994).
6. Gothert M, Schlicker E, Fink K and Classen K. Arch Int Pharmacodyn Ther 288, 31-42 (1987).
7. Maura G and Raiteri M. Eur J Pharmacol 129, 333-337 (1986).
8. Buzzi MG, Carter WB, Shimizu T et al. Neuropharmacology 30, 1193-1200 (1991).
9. Arvieu L, Mauborgne A, Bourgoin S et al. NeuroReport 7, 1973-1976 (1996).
10. Pineyro G, Castanon N, Hen R and Blier P. NeuroReport 7, 353-359 (1995)
11. Shuey DL, Sadler TW, Tamir H and Lauder JM. Anat Embryol 187, 75-85 (1993).
12. Shuey DL, Sadler TW and Lauder JM. Teratology 46, 367-378 (1992).
13. Lauder JM. Trends Neurosci 16, 233-240 (1993).
14. Choi D-S, Ward SJ, Messadeq N et al. Development 124, 1745-1755 (1997).
15. Seuwen K, Magnaldo I and Pouyssegur J. Nature 335, 254-256 (1988).
16. Pauwels PJ, Wurch T, Palmier C and Colpaert FC. Naunyn Schmiedeberg's Arch Pharmacol 354, 136-144 (1996).
17. Merzak A, Koochekpour S, Fillion M-P et al. Mol Brain Res 41, 1-7 (1996).
18. Cattaneo MG, Palazzi E, Bondiolotti G and Vicentinni LM. Eur J Pharmacol 268, 425-430 (1994).
19. Bolanos-Jiménez F, Manhaes de Castro R, Seguin L et al. Eur J Pharmacol 294, 531-540 (1995).
20. Boulenguez P et al. J Neurochem 58, 951-959 (1992).
21. Hartig PR, Hoyer D, Humprey PPA and Martin GR. Trends Pharmacol Sci 17, 103-105 (1996).
22. Hartig PR, Branchek TA and Weinshank RL. Trends Pharmacol Sci 13, 155-159 (1992).
23. Choudhary MS, Craigo S and Roth BL. Mol Pharmacol 42, 627-633 (1992).
24. Pranzatelli MR and Galvan I. Neurosci Lett 167, 166-170 (1994).
25. Bennet-Clarke CA, Leslie MJ, Chiaia NL and Rhoades RW. Proc Natl Acad Sci USA 90, 153-157 (1993).
26. Peroutka SJ. Bio Signals 3, 217-222 (1994).